Partner
TEL |
+82-2-6386-6284 |
E-MAIL |
yein.han@leeko.com |
|
|
Yein Han is a partner at Lee & Ko specializing in intellectual property law and pharmaceutical affairs. She graduated from the Sungkyunkwan University Law School in 2012. In addition to her legal qualifications, she holds a B.S. in Pharmacy from the same university and obtained a pharmacist's license in 2008. Prior to joining Lee & Ko in 2016, she was involved in prosecuting pharmaceutical-related patents at a large prosecution firm in Korea, FirtLaw P.C. and Y.P.LEE, MOCK. Ms. Han represented many multinational and domestic companies in patent litigations covering pharmaceuticals, biotech drugs, and chemical industries. Also, she has extensive experience in handling a wide range of IP litigation cases including business trade and unfair competition acts. Ms. Han advised and represented numerous foreign pharmaceutical companies, medical device companies, cosmetic companies, chemical companies in administrations and administrative reviews before the MFDS/Environment Government Authority and appeals before the administrative law courts in connection with new drug applications, drug-pricing, pre-registration, labeling, orphan drug designation, IND approval, and advertising matters. She also represented chemical company in product liability case.
Education
2020 |
Admitted to New York Bar |
2020 |
UCLA Law School - LL.M |
2015 |
Sungkyunkwan Law School - Ph.D. Course Completion |
2012 |
Sungkyunkwan Law School - J.D. |
2008 |
Admitted to Korea Pharmaceutical Association |
2008 |
Sungkyunkwan University - B.S. in Pharmacy |
Work Experience
2016-Present |
Lee & Ko |
2013-2015 |
FirstLaw P.C. |
2012 |
Y.P.LEE, MOCK |
Expertise
IP Litigation |
Trade Secret · Company Information Protection |
Responding to Unfair Competition |
Healthcare · Life Sciences |
IP Strategy Consulting |
IP Compliance |
IP Transactions · Licensing |
Admissions
Expert Committee on In vitro Diagnostic Medical Devices(2022) |
Admitted to bar, New York(2020) |
Admitted to the Korean patent bar(2014) |
Admitted to bar, Korea (2012) |
Admitted to Korea Pharmaceutical Association(2008) |
Languages
Publications / Presentations / ETC
- Patent Right Infringement of a Second Medical Use Invention: Focusing on the Pregabalin Decision (Seoul Central Court 2016 Gahab 517156 Decision) (Sungkyunkwan Law Review Vol. 32 No. 4, December 2020)